BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2736769
Number of visits today
492
Number of downloads
2007665
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Mitusova K, Peltek OO, Karpov TE, Muslimov AR, Zyuzin MV, Timin AS. Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01610-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Miao YB, Zhao W, Renchi G, Gong Y, Shi Y. Customizing delivery nano-vehicles for precise brain tumor therapy. J Nanobiotechnology 2023;21:32. [PMID: 36707835 DOI: 10.1186/s12951-023-01775-9] [Reference Citation Analysis]
2 Dean PT, Hooks SB. Pleiotropic effects of the COX-2/PGE2 axis in the glioblastoma tumor microenvironment. Front Oncol 2023;12. [DOI: 10.3389/fonc.2022.1116014] [Reference Citation Analysis]
3 Obozina AS, Komedchikova EN, Kolesnikova OA, Iureva AM, Kovalenko VL, Zavalko FA, Rozhnikova TV, Tereshina ED, Mochalova EN, Shipunova VO. Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo. Pharmaceutics 2023;15. [PMID: 36678860 DOI: 10.3390/pharmaceutics15010231] [Reference Citation Analysis]
4 Semyachkina-Glushkovskaya O, Terskov A, Khorovodov A, Telnova V, Blokhina I, Saranceva E, Kurths J. Photodynamic Opening of the Blood-Brain Barrier and the Meningeal Lymphatic System: The New Niche in Immunotherapy for Brain Tumors. Pharmaceutics 2022;14. [PMID: 36559105 DOI: 10.3390/pharmaceutics14122612] [Reference Citation Analysis]
5 Hedna R, Kovacic H, Pagano A, Peyrot V, Robin M, Devred F, Breuzard G. Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma. Cancers 2022;14:5386. [DOI: 10.3390/cancers14215386] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345